PositiveID Corporation (NASDAQ:PSID) gained 28.20% up to $1.50 with volume surging on no news. PSID is trading above its 200 day moving average of $1.03, and edging closer to its all time high of $1.65. PositiveID Corporation previously conducted business as VeriChip Corporation but changed its name to PositiveID Corporation on November 11^th 2009.   The medical application of the company’s proprietary RFID chip was recently profiled by Forbes, and The Journal of American Chemical Society, touting the technology’s potential to revolutionize the diabetes testing market, worldwide. The diabetes testing market is currently estimated to be valued at about $8 billion; the ever-increasing occurrence of diabetes is resulting in higher volumes of diagnostic tests, which is driving strong growth at an annual rate of about 7 percent.

Headquartered in Delray Beach, Florida, PositiveID Corporation develops, markets, and sells RFID systems to identify, locate, and protect people and assets in the healthcare market  around the world.  The company has business activities in three markets: Healthcare Security, which  is an infant protection system; Implantable serves the VeriMed system, in which human RFID microchips are implanted for patient identification and security purposes; the Industrial application sells vibration monitoring tools for engineering, construction, and mining professionals to measure the effects of human induced vibrations from explosives; and Asset Management systems used by industrial companies to manage and track their mobile equipment and tools.  The ultimate applications of RFID chips are much broader than healthcare and can eventually be used in all forms of identification including banking. In March 2009, PositiveID established a subsidiary, VeriGreen Energy Corporation, to focus and supply the clean and alternative energy sector.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) rose 12.23% up to $2.05 on no news today; however anticipation of tomorrow’s Q4 financial results is driving the stock.  Oculus will host a conference call tomorrow at 4:30 EST for all shareholders and interested parties. Last week the company announced marketing plans for it’s recently FDA approved Microcyn Technology platform for the irrigation and management of post-surgical wounds. The company has received clearance from health agencies throughout the US, Europe, India, China and Mexico and select Middle East countries. Oculus’ Microcyn Technology has treated over two million patients worldwide and has been used in 30 clinical studies, without any adverse effect.  Based in Petaluma, California, Oculus Innovative Sciences is a biopharmaceutical company which develops, manufactures and markets products based upon Microcyn Technology platform, including formulations designed to significantly reduce the need for antibiotics to fight infections.

Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) jumped 18.70% up to $2.73 on no news. Next week Somaxon’s CEO Richard Pascoe, will participate at the 12th Annual BIO CEO & Investor Conference at the Waldorf-Astoria in New York, Monday, February 8th at 9:30 A.M. In January the sleep drug maker refilled its New Drug Application (NDA) on behalf of Silenor (doxepin) with the FDA, seeking approval for its drug candidate for the treatment of insomnia.  On December 7th 2009, the FDA declined Silenor for the second time that year; the stock spiralled down some 72% by mid-December, where it was trading around $0.928.  Fortunately the clinical safety of the drug was not an issue for the FDA; however the government agency was not satisfied with the efficacy standard for sustained sleep required to maintain effectiveness in adults with insomnia. The review is expected to be completed sometime in mid-March 2010. Headquartered in San Diego, California, Somaxon is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the central nervous system such as insomnia.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

The Talbots Inc. (NYSE: TLB), $8.64, +1.43, 19.83%, announced that it has entered into a definitive merger agreement where it will acquire BPW Acquisition Corp for $350 million. The proceeds of BPW’s cash-in-trust of approximately $350 million will go towards retiring all of Talbots’ existing debt.  Talbots will also acquire all of the outstanding shares of Talbots common stock held by AEON Inc. which represents a current stake of over 54%.   Talbots is a specialty retailer of women’s apparel.  The company has made gains of over 19%, hitting a high of $9.05.

QuadraMed Corporation (NASDAQ: QDHC), $8.33, +1.92, 29.95%, hit a high today of 8.40 and is trading near the day’s low of 8.32.  QDHC has made gains of over 29% with 2.4 million shares trading hands on the announcement that it has entered into an agreement to be acquired by Francisco Partners for payment of all of its outstanding common shares at $8.50 per share in cash and all of the outstanding shares of QDHC’s Series A Cumulative Mandatory Convertible Preferred Stock for $13.7097 per share in cash.  A deal valued at $126 million.  QuadraMed provides information technology solutions for healthcare enterprises. 

Bio Time Inc. (AMEX: BTIM), $4.85, +0.72, 17.44%, is a biomedical research and product development company responsible for developing blood plasma volume expanders and related technology which can prove beneficial in surgery, emergency trauma treatment and other applications.  Bio Time is trading with significantly higher then normal volume and making gains of over 17%, hitting a low of the day at 4.38 to a high of 5.25.  The company CEO, Michael D. West, rang The Opening Bell at the New York Stock Exchange today to mark the company’s recent listing on the NYSE Amex.

Invisa Inc. (OTCBB: INSA), $0.034, +0.026, 325.00%, is trading up 325% at the day’s high of 0.034 with significantly higher then usual volume of 2.6 million shares on no news.  Invisa Inc. is in its development stage commercializing patented presence-sensing technology.  The Company manufactures and sells sensors that use its patented InvisaShield presence-sensing design and technology. 

deCode Genetics Inc. (NASDAQ: DCGN), $0.098, +0.055, 128.60%, is a bio-pharmaceutical company focused on analyzing and understanding the human genome.  deCode has reached a low of 0.038 to a high of 0.118, presently trading with gains of over 128% on no news.  The last announcement was on the delisting notice from the NASDAQ Stock Market but the company has appealed the suspension.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

InfoLogix, Inc. (NASDAQ:IFLG) advanced 23.08% to close at $0.160 on no news; however last week the company announced coming to terms on a restructuring agreement with its senior lender, Hercules Technology Growth Capital, Inc. Hercules converted InfoLogix’s debt into equity and increased borrowing capacity up to $5 million, which will finance the wireless technology company’s planned expansion into healthcare and commercial markets.  Headquartered in Hatboro, Pennsylvania, InfoLogix Inc provides mobile technology solutions for the workplace. The company’s services include electronic medical record system installation and support, computerized healthcare information systems, and strategic cost management.  InfoLogix also provides software products for wireless patient tracking, equipment position tracking, procedure tracking, and patient security; asset tracking and management solutions; radio frequency identification (RFID) solutions for vehicle tracking and fleet management, and warehousing logistics.

Targeted Genetics Corporation (NASDAQ:TGEN) jumped 22.45% to close at $0.300 on no news.  The most recent company news dates back 3 weeks ago when Targeted Genetics revealed that third quarter income rose to $671,000, or 3 cents per share, compared to a loss of $2.7 million, or a loss of 13 cents per share for the same quarter in 2008.  The company reported revenue rose to $3.7 million from $1.7 million in 2008. Based in Seattle, Washington, Targeted Genetics Corporation is a clinical-stage biotech company which researches and develops gene therapy products and technologies for treating various diseases.  The company currently has clinical trials for vaccine and treatment candidates for HIV, heart failure, inflammatory arthritis, rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis and amyotrophic lateral sclerosis.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

QLT Inc. (USA) (NASDAQ:QLTI) rose 15.97% up to $4.37 on news QLT has settled a lawsuit brought by Massachusetts General Hospital.  QLT will pay $20 million to the Massachusetts General Hospital which has agreed to drop their lawsuit against QLT. QLT developed Visudyne, which treats age-related vision conditions, in cooperation with Massachusetts General and the Massachusetts Eye and Ear Infirmary.  Massachusetts General launched its suit in February on grounds that it was entitled to higher revenues from Visudyne sales. Headquartered in Vancouver, Canada, QLT Inc is a biopharmaceutical company which discovers, develops, and commercializes pharmaceutical products, primarily for ophthalmology and eye care.  The company’s Visudyne photosensitizer treats eye disease, known as age related macular degeneration; and severe near-sightedness, and presumed ocular histoplasmosis or other eye diseases.

Repros Therapeutics Inc. (NASDAQ:RPRX) gained 16.90% up to $0.822 on no news with 1,048,129 shares moving this afternoon. Based in The Woodlands, Texas, Repros Therapeutics is a development-stage biopharmaceutical company developing drug therapies for the treatment of serious female pelvic conditions, such as treatment of uterine fibroids, anaemia associated with excessive menstrual bleeding relating to uterine fibroids, and anaemia associated with uterine fibroids and endometriosis.  Repros Therapeutics has three late stage drug candidates in trials.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

ARCA biopharma, Inc. (NASDAQ:ABIO) skyrocketed 88.89%  up to $4.25 on news the US Food and Drug Administration has selected its drug Gencaro for a Fast Track development program. The FDA is investigating the drug for the reduction of cardiovascular mortality and cardiovascular hospitalization in a genotype-defined heart failure population. The drug candidate could begin clinical trial by late 2010.  Headquartered in Broomfield, Colorado, ARCA Biopharma Inc. is a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases in the US.

TLC Vision Corporation (USA) (NASDAQ:TLCV) jumped 22.73% up to $2.70 on no official news. Based in Mississauga, Ontario, TLC Vision Corporation is an eye care services company providing care directly to patients and as a partner with their doctors and facilities. The company owns and operates refractive centers which offer laser treatments for common refractive vision disorders such as myopia, hyperopia and astigmatism.   According to the corporate website, the company generates approximately $300 million in annual business activity.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Calgary, Alberta - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles.  Please visit us at PicksThatMove.com to view more of our profiled stocks.

Interleukin Genetics Inc Leads Biopharmaceutical Gainers

The hot stock information of the day includes:   ILI, NEXM

Interleukin Genetics Inc (AMEX:ILI) advanced 22.96% up to $0.910 on no news; however the company is due to disclose Q3 financial results and host a conference call tomorrow, November 12th after the close of the market to discuss the report.  Headquartered in Waltham, Massachusetts Interleukin Genetics develops and commercializes personally tailored health care products in the US and internationally.   Interleukin Genetics has research collaborations with the University of Sheffield, Tufts University, New York University, Harvard University, the Mayo Clinic, California Pacific Medical Center, Boston University, the University of Arkansas, Tongji Medical College, University of North Carolina, and Yonsei University.

NexMed Inc. (NASDAQ:NEXM) gained 16.80% up to $0.1490 on news the company has raised $750,000 in gross proceeds from the issuance of new convertible notes due on December 31st, 2011.  The notes are secured by a mortgage on NexMed’s facility in East Windsor, New Jersey. Headquartered in East Windsor, New Jersey, NexMed, Inc., focuses its efforts on bio-enhancement drug delivery technology known as NexACT, which enables an active drug to be better absorbed through the skin.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Calgary, Alberta - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles.  Please visit us at PicksThatMove.com to view more of our profiled stocks.

APY, IFLG: Secured Electronic Data Management And Medical RFID Is Hot Technology

The hot stock information of the day includes:  APY, IFLG

Aspyra Inc. (AMEX:APY) jumped 50.38%up to $0.20 in early afternoon trading on no news.  The medical diagnostic imaging technology company will launch its proprietary AccessNET product at the upcoming RSNA 2009 Annual Meeting in Chicago, Illinois from November 29^th to December 3^rd 2009. The company’s Picture Archive Communication System (PACS) provides a digital mammogram display for x-ray image assessment and simplified data transfer to remote locations.  Headquartered in Westlake Village, California, Aspyra Inc is a healthcare information technology and service company which develops and markets clinical information systems and diagnostic information systems for healthcare providers in the US and Canada.

InfoLogix, Inc. (NASDAQ:IFLG) advanced 14.43% up to $0.160 on no news.  Headquartered in Hatboro, Pennsylvania, InfoLogix Inc provides mobile technology solutions for the workplace. The company’s services include electronic medical record system installation and support, computerized healthcare information systems, and strategic cost management.  InfoLogix also provides software products for wireless patient tracking, equipment position tracking, procedure tracking, and patient security; asset tracking and management solutions; radio frequency identification (RFID) solutions for vehicle tracking and fleet management, and warehousing logistics.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

Calgary, Alberta - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles.  Please visit us at PicksThatMove.com to view more of our profiled stocks.

VeriChip Leads Healthcare Technology Gainers With Volume

The hot stock information of the day includes:  CHIP, VIAP

VeriChip Corporation (NASDAQ:CHIP) jumped 26.53% to close at $1.86 with 1,913,054 shares traded on no news.  Last week the company was honoured by the South Florida Business Journal’s 2009 Technology Awards for their innovative hardware.  Headquartered in Delray Beach, Florida, VeriChip Corporation develops, markets, and sells RFID systems to identify, locate, and protect people and assets in the healthcare market  around the world.  The company has business activities in three markets: Healthcare Security, which  is an infant protection system; Implantables serves the VeriMed system with implantable human RFID microchips for  patient identification and security purposes; and finally the Industrial application sells vibration monitoring tools for engineering, construction, and mining professionals to measure the effects of human induced vibrations, such as blasting activity, and asset management systems used to manage and track their mobile equipment and tools.  The potential ultimate application of RFID chips is much broader than healthcare and can eventually be used in all forms of identification including banking.  VeriChip’s stock has appreciated 397% since January.

VIA Pharmaceuticals Inc. (NASDAQ:VIAP) gained 19.73% to close $0.449 on no news. Headquartered in San Francisco, California, VIA Pharmaceuticals Inc is a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease.  The company currently has three drug candidates in development.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Calgary, Alberta - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles.  Please visit us at PicksThatMove.com to view more of our profiled stocks.

Small Cap Technology Making Double Digit Gains 

The hot stock information of the day includes:   CHIP, TKO 

VeriChip Corporation (NASDAQ:CHIP) rose 15.80% up to $2.49 on news the company received an exclusive license to its partner RECEPTOR’s sensing technology to develop an in vivo glucose-sensing RFID microchip to explore new treatments for Diabetes.  Headquartered in Delray Beach, Florida, VeriChip Corporation develops, markets, and sells RFID systems to identify, locate, and protect people and assets in the healthcare market  around the world.   The company has business activities in three markets: Healthcare Security, which  is an infant protection system, Implantables serves the VeriMed system, in which human RFID microchips are implanted for  patient identification and security purposes, and the Industrial applications sells vibration monitoring tools for engineering, construction, and mining professionals to measure the effects of human induced vibrations, such as blasting activity; and asset management systems used by industrial companies to manage and track their mobile equipment and tools.  The potential ultimate application of RFID chips is much broader than healthcare and can eventually be used in all forms of identification including banking. 

Telkonet, Inc. (AMEX:TKO) gained 16.59% up to $0.350 on no news.  Headquartered in Germantown, Maryland, Telkonet is the leading provider of innovative, centrally managed solutions for integrated energy management, wired and wireless networking, building automation and customer support services.

To be kept up to date on all of our hot stock information join us at Picks That Move. 

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock.